US equities
|
ANT
$100.04
▲+20.53%
NVDA
$149.84
▼-0.74%
AMD
$489.68
▼-7.63%
MU
$703.24
▼-0.29%
SPCX
$137.58
▼-4.13%
SNDK
$775.73
▼-0.06%
MSFT
$509.15
▲+0.17%
AAPL
$349.56
▼-0.82%
ANT
$100.04
▲+20.53%
NVDA
$149.84
▼-0.74%
AMD
$489.68
▼-7.63%
MU
$703.24
▼-0.29%
SPCX
$137.58
▼-4.13%
SNDK
$775.73
▼-0.06%
MSFT
$509.15
▲+0.17%
AAPL
$349.56
▼-0.82%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Samuel Yeroushalmi
Recent news which mentions Samuel Yeroushalmi
Medical Cannabis For Skin Conditions: Patients Say Yes, Docs Need More Info, Study Finds
February 14, 2022
Tags
Market News
Dermatology
Samuel Yeroushalmi
From
Benzinga